Development of “Baby, Me, & NRT”: A Behavioral Intervention to Improve the Effectiveness of Nicotine Replacement Therapy in Pregnancy
Nicotine and Tobacco Research · 2023
DOI: 10.1093/ntr/ntad102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2023. Verfasst von Lisa McDaid und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, University of East Anglia, Norwich NR4 7UL, UK. Hauptthemen laut MEDLINE: Behavior Therapy, Smoking Cessation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute for Health Research.
Abstract (Originalsprache)
Background
The effectiveness of Nicotine Replacement Therapy (NRT) for smoking cessation in pregnancy is limited by inconsistent and incorrect use. This paper describes the development process for “Baby, Me, & NRT”, a novel pregnancy-specific intervention aimed at enhancing adherence to NRT.
Methods
An integrated approach to intervention development was used, combining evidence, theory, stakeholders’ feedback, and tailoring principles. The process involved six iterative steps: (1) synthesizing relevant published evidence and guidance, (2) collecting primary qualitative data on barriers and facilitators to NRT adherence along with potential intervention design features, (3) identifying relevant behavioral theories and mapping the evidence against these, (4) prioritizing behavioral determinants identified in steps 1 and 2, generating intervention objectives, and identifying behavior change techniques which target the prioritized determinants, (5) consulting with stakeholders on intervention components, key content and tailoring features, and (6) producing a prototype intervention along with implementation guidance.
Results
The prototype intervention comprises of a multi-component, 1-month cessation programme, which includes six enhanced behavioral support sessions delivered by a trained advisor, tailored text messages, a website, and an illustrated booklet. It promotes the uptake of high-dose and combination NRT, emphasizes the importance of adherence, addresses motivation to use NRT, proactively helps problem solve NRT use issues, and provides guidance on preventing and managing smoking lapses.
Conclusion
The development process generated an evidence- and theory-guided intervention, designed with stakeholder input, aimed at improving NRT effectiveness for smoking cessation in pregnancy. The prototype intervention has since been optimized and is being evaluated in a randomized controlled trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Health Sciences, University of East Anglia, Norwich NR4 7UL, UK.
- Division of Primary Care, University of Nottingham, Nottingham NG7 2RD, UK.
ORCID-Profile: Lisa McDaid, Joanne Emery, Tim Coleman, Darren Kinahan-Goodwin, Lucy Phillips, Felix Naughton
Förderung
- National Institute for Health Research
Zitieren
APA
McDaid, L., Emery, J., Thomson, R., Coleman, T., Cooper, S., Dickinson, A., Kinahan-Goodwin, D., Phillips, L., & Naughton, F. (2023). Development of “Baby, Me, & NRT”: A Behavioral Intervention to Improve the Effectiveness of Nicotine Replacement Therapy in Pregnancy. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntad102
Vancouver
McDaid L, Emery J, Thomson R, Coleman T, Cooper S, Dickinson A, et al. Development of “Baby, Me, & NRT”: A Behavioral Intervention to Improve the Effectiveness of Nicotine Replacement Therapy in Pregnancy. Nicotine and Tobacco Research. 2023. doi:10.1093/ntr/ntad102
BibTeX
@article{McDaid2023,
author = {McDaid, Lisa and Emery, Joanne and Thomson, Ross and Coleman, Tim and Cooper, Sue and Dickinson, Anne and Kinahan-Goodwin, Darren and Phillips, Lucy and Naughton, Felix},
title = {Development of “Baby, Me, & NRT”: A Behavioral Intervention to Improve the Effectiveness of Nicotine Replacement Therapy in Pregnancy},
journal = {Nicotine and Tobacco Research},
year = {2023},
doi = {10.1093/ntr/ntad102}
}
EUVIMED